We are live on ! Find out more
LJHT

Laurie J. Hall Trustee Portfolio holdings

AUM $322M
1-Year Est. Return 33.73%
This Fund
S&P 500
This Quarter Est. Return
+0.01%
1 Year Est. Return
+33.73%
3 Year Est. Return
+96.04%
5 Year Est. Return
+120.73%
10 Year Est. Return
AUM
$259M
AUM Growth
-$6.07M
Cap. Flow
-$5.16M
Cap. Flow %
-1.99%
Top 10 Hldgs %
33.43%
Holding
339
New
13
Increased
10
Reduced
142
Closed
9

Top Buys

Rank Stock Value
1
ACGL icon
Arch Capital
ACGL
+$188K
2
MDT icon
Medtronic
MDT
+$166K
3
BXP icon
Boston Properties
BXP
+$149K
4
SPGI icon
S&P Global
SPGI
+$62.8K
5
ALLE icon
Allegion
ALLE
+$55.6K

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$634K
2
SYK icon
Stryker
SYK
+$383K
3
INTC icon
Intel
INTC
+$267K
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$259K
5
COST icon
Costco
COST
+$253K

Sector Composition

Rank Sector Weight
1 Healthcare 24.7%
2 Technology 23.89%
3 Industrials 12.69%
4 Consumer Staples 8.19%
5 Communication Services 8.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SREV
276
DELISTED
ServiceSource International, Inc.
SREV
$10K ﹤0.01%
7,216
DISCK
277
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$10K ﹤0.01%
400
-240
-38% -$6.41K
CYTK icon
278
Cytokinetics
CYTK
$10.4B
$9K ﹤0.01%
240
-150
-38% -$4.42K
IONS icon
279
Ionis Pharmaceuticals
IONS
$9.4B
$9K ﹤0.01%
270
-160
-37% -$6.03K
LVS icon
280
Las Vegas Sands
LVS
$29.6B
$9K ﹤0.01%
250
-750
-75% -$32.2K
LXRX icon
281
Lexicon Pharmaceuticals
LXRX
$1.1B
$8K ﹤0.01%
1,650
-1,230
-43% -$5.05K
PRTA icon
282
Prothena Corp
PRTA
$450M
$8K ﹤0.01%
110
-220
-67% -$13.7K
RARE icon
283
Ultragenyx Pharmaceutical
RARE
$2.55B
$8K ﹤0.01%
90
-50
-36% -$4.52K
SRPT icon
284
Sarepta Therapeutics
SRPT
$1.77B
$8K ﹤0.01%
85
-50
-37% -$3.85K
DDOG icon
285
Datadog
DDOG
$84B
$7K ﹤0.01%
50
VMEO
286
DELISTED
Vimeo
VMEO
$7K ﹤0.01%
235
-130
-36% -$5.13K
SPLK
287
DELISTED
Splunk Inc
SPLK
$7K ﹤0.01%
50
AFRM icon
288
Affirm
AFRM
$25.2B
$6K ﹤0.01%
+50
New +$4K
ATRA icon
289
Atara Biotherapeutics
ATRA
$76.1M
$6K ﹤0.01%
14
-8
-36% -$2.87K
MGNX icon
290
MacroGenics
MGNX
$257M
$6K ﹤0.01%
280
-160
-36% -$3.85K
NET icon
291
Cloudflare
NET
$107B
$6K ﹤0.01%
+50
New +$5.97K
SAGE
292
DELISTED
Sage Therapeutics
SAGE
$6K ﹤0.01%
130
+50
+63% +$2.29K
SSYS icon
293
Stratasys
SSYS
$774M
$6K ﹤0.01%
290
-170
-37% -$3.69K
ITCI
294
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$6K ﹤0.01%
160
-110
-41% -$3.82K
NOK icon
295
Nokia
NOK
$52.3B
$5K ﹤0.01%
1,000
PTCT icon
296
PTC Therapeutics
PTCT
$6.12B
$5K ﹤0.01%
145
+25
+21% +$1.03K
SSP icon
297
E.W. Scripps
SSP
$304M
$5K ﹤0.01%
300
-180
-38% -$3.33K
AERI
298
DELISTED
Aerie Pharmaceuticals
AERI
$5K ﹤0.01%
410
-260
-39% -$3.8K
CARS icon
299
Cars.com
CARS
$660M
$4K ﹤0.01%
316
CRNC icon
300
Cerence
CRNC
$414M
$4K ﹤0.01%
+40
New +$4.37K

Similar funds

Laurie J. Hall Trustee's Q3 2021 Portfolio in Review

As of Q3 2021, Laurie J. Hall Trustee held 339 positions worth $259M, down 2.3% from $265M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Laurie J. Hall Trustee's Q3 2021 filing shows 13 new, 10 increased, 142 reduced and 9 closed positions. Its largest new stake was Arch Capital: 4,739 shares worth $181K. The largest sale was Microsoft, an estimated $634K.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.

  • Laurie J. Hall Trustee's largest Q3 2021 buy was Arch Capital: 4,739 shares worth $181K.
  • Laurie J. Hall Trustee added most to Medtronic in Q3 2021, an estimated $166K increase.
  • Laurie J. Hall Trustee's biggest Q3 2021 reduction was Microsoft, cutting an estimated $634K.
  • Laurie J. Hall Trustee fully exited Hartford Financial Services in Q3 2021, selling an estimated $31K.
  • Laurie J. Hall Trustee's ten largest holdings make up 33% of its $259M portfolio in Q3 2021.
  • Laurie J. Hall Trustee opened 13 new positions and closed 9 in Q3 2021.
  • Laurie J. Hall Trustee's portfolio value fell 2.3% quarter-over-quarter to $259M.

Based on Laurie J. Hall Trustee's 13F filing for Q3 2021, filed 4 Oct 2021.